ACA premiums expected to rise 7% in 2025, report finds

Plans sold on exchanges as part of the Affordable Care Act (ACA) are expected to see a price hike next year.

According to healthcare policy research firm KFF, premiums for plans will rise by around 7% in 2025. However, KFF notes, those who receive subsidies to buy plans are unlikely to experience that full price bump—but ultimately, that means Congress will need to spend more to fund those subsidies.

As for the primary factors driving costs, KFF said insurers cited higher prices from providers and growing demand for expensive GLP-1 drugs, mainly weight loss and diabetes drug Ozempic. But notably, the number of Americans forced to buy insurance on exchanges has also gone up significantly, as Medicaid redetermination pushed them off government plans.

Hospital consolidation, healthcare staffing shortages and general inflation were also cited as contributing factors.

The report from KFF is just a preliminary survey of insurers, and rates will not be finalized until later this year. The expected price change in plans varies dramatically, but most premiums will increase somewhere in the range of 5% to 10%.

KFF_ACA_Premiums

For those who do not receive subsidies to buy insurance from ACA marketplaces, KFF warns, increases may make plans unaffordable, ultimately driving up the count of uninsured Americans.

The full analysis from KFF can be found here.

Chad Van Alstin Health Imaging Health Exec

Chad is an award-winning writer and editor with over 15 years of experience working in media. He has a decade-long professional background in healthcare, working as a writer and in public relations.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”